Hi 

Exciting news from the MindBio Therapeutics team!

A recent article in this month's issue of New Scientist, titled "Microdosing LSD extends sleep the following night," discusses the fascinating findings from our Phase 1 clinical trial involving microdosing LSD.

Click Here!

During this rigorous scientific journey, our dedicated team of researchers discovered an unexpected yet significant outcome - microdosing LSD not only had no negative impact on sleep but actually extended the sleep duration on the night following microdosing!

Participants receiving a microdose of LSD slept an extra 24.3 minutes per night compared to the placebo group.

Even more interesting is that these changes were not due to alterations in sleep stages or physical activity.

This outcome, while unanticipated, brings to light the potential influence of microdosing LSD on sleep patterns, adding another dimension to the therapeutic potential of psychedelic substances.

The implications of this research are substantial, especially for conditions such as major depressive disorder, where sleep disturbances are common.

At MindBio Therapeutics, we are dedicated to exploring the full potential of psychedelic therapies and their ability to enhance mental wellness.

Stay tuned for more groundbreaking research from MindBio Therapeutics and check out the full article in the New Scientist for more details!

Justin Hanka 

Cofounder and Chief Executive

Receive our latest updates here:

https://www.mindbiotherapeutics.com/get-updates

Follow MindBio on LinkedIn:

https://www.linkedin.com/company/mindbio-therapeutics/?viewAsMember=true

Follow CEO Justin Hanka on LinkedIn: 

https://www.linkedin.com/in/justinhanka/